HCA Healthcare Could See AI-Driven Multiple Expansion, UBS Says

MT Newswires Live00:07

HCA Healthcare (HCA) could see productivity gains from artificial intelligence that support valuation multiple expansion, UBS said Monday, raising its price target on the stock to $635 from $598 and maintaining a buy rating.

The firm said HCA's scale and data advantages position it to benefit from AI adoption across administrative, operational and clinical workflows, potentially improving efficiency in a hospital sector that has historically seen modest productivity growth.

UBS also noted growing investor interest in healthcare companies viewed as potential AI beneficiaries, which could help the stock break above its long-standing 8x to 10x EV/EBITDA trading range.

Additionally, the bank said potential Medicaid supplemental payment updates across several states could provide upside to 2026 estimates.

Price: 543.99, Change: +11.69, Percent Change: +2.20

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2613733713?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-24 00:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2613733713","market":"sg","top_or_hot":-1,"title":"HCA Healthcare Could See AI-Driven Multiple Expansion, UBS Says","media":"MT Newswires Live","content":"<html><body><p> HCA Healthcare (HCA) could see productivity gains from artificial intelligence that support valuation multiple expansion, UBS said Monday, raising its price target on the stock to $635 from $598 and maintaining a buy rating.</p><p>The firm said HCA's scale and data advantages position it to benefit from AI adoption across administrative, operational and clinical workflows, potentially improving efficiency in a hospital sector that has historically seen modest productivity growth.</p><p>UBS also noted growing investor interest in healthcare companies viewed as potential AI beneficiaries, which could help the stock break above its long-standing 8x to 10x EV/EBITDA trading range.</p><p>Additionally, the bank said potential Medicaid supplemental payment updates across several states could provide upside to 2026 estimates.</p><p>Price: 543.99, Change: +11.69, Percent Change: +2.20</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HCA Healthcare Could See AI-Driven Multiple Expansion, UBS Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHCA Healthcare Could See AI-Driven Multiple Expansion, UBS Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-02-24 00:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> HCA Healthcare (HCA) could see productivity gains from artificial intelligence that support valuation multiple expansion, UBS said Monday, raising its price target on the stock to $635 from $598 and maintaining a buy rating.</p><p>The firm said HCA's scale and data advantages position it to benefit from AI adoption across administrative, operational and clinical workflows, potentially improving efficiency in a hospital sector that has historically seen modest productivity growth.</p><p>UBS also noted growing investor interest in healthcare companies viewed as potential AI beneficiaries, which could help the stock break above its long-standing 8x to 10x EV/EBITDA trading range.</p><p>Additionally, the bank said potential Medicaid supplemental payment updates across several states could provide upside to 2026 estimates.</p><p>Price: 543.99, Change: +11.69, Percent Change: +2.20</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LABU","symbol_name":"三倍做多标普生物-Direxion","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2613733713","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2613733713","pubTimestamp":1771862827,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"HCA Healthcare  could see productivity gains from artificial intelligence that support valuation multiple expansion, UBS said Monday, raising its price target on the stock to $635 from $598 and maintaining a buy rating.The firm said HCA's scale and data advantages position it to benefit from AI adoption across administrative, operational and clinical workflows, potentially improving efficiency in a hospital sector that has historically seen modest productivity growth.UBS also noted growing investor interest in healthcare companies viewed as potential AI beneficiaries, which could help the stock break above its long-standing 8x to 10x EV/EBITDA trading range.Additionally, the bank said potential Medicaid supplemental payment updates across several states could provide upside to 2026 estimates.Price: 543.99, Change: +11.69, Percent Change: +2.20","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LABU":"三倍做多标普生物-Direxion","LU0310799852.SGD":"FTIF - Templeton Global Equity Income A MDIS SGD","LU1119994496.HKD":"FIDELITY WORLD \"A\" (HKD) ACC","LU0068578508.USD":"First Eagle Amundi International Cl AU-C USD","LU1267930490.SGD":"TEMPLETON GLOBAL EQUITY INCOME \"AS\" (SGD) INC A","BK4585":"ETF&股票定投概念","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","LU1150488218.USD":"First Eagle Amundi Income Builder AU2-MD USD","XBI":"SPDR S&P Biotech ETF","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU0211328371.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (MDIS) (USD)   INC","LU0882574055.USD":"富达全球健康医疗A ACC","LU0029864427.USD":"TEMPLETON GLOBAL \"A\" (USD) INC","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","LU1261432733.SGD":"Fidelity World A-ACC-SGD","IE00B775SV38.USD":"NEUBERGER BERMAN US MULTICAP OPPORTUNITIES \"A\" (USD) ACC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU1150488135.SGD":"First Eagle Amundi Income Builder AHS-MD SGD-H","LU0128525929.USD":"TEMPLETON GLOBAL \"A\" (USD) ACC","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","BK4504":"桥水持仓","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","LU0187121727.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) INC","XLV":"健康照护类股ETF-SPDR","BK4588":"碎股","LU0985489474.SGD":"First Eagle Amundi International AHS-C SGD-H","LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","HCA":"HCA控股","LU2244417387.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) ACC","LU0878866978.SGD":"First Eagle Amundi International AHS-QD SGD-H","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC","LU1489326972.SGD":"First Eagle Amundi International AHS-MD SGD-H","BK4185":"保健护理机构","SG9999014039.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) INC","LU0310800379.SGD":"FTIF - Templeton Global A Acc SGD","LU1267930573.SGD":"TEMPLETON GLOBAL \"AA\" (SGD) ACC A","LU0433182093.SGD":"First Eagle Amundi International AS-C SGD","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","BK4581":"高盛持仓","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD","IE00B3S45H60.SGD":"Neuberger Berman US Multicap Opportunities A Acc SGD-H"},"translate_title":"瑞银表示，HCA Healthcare可能会看到人工智能驱动的多重扩张","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCA":1.5,"XBI":0.6,"XLV":1.5,"LABU":0.6},"content_text":"HCA Healthcare (HCA) could see productivity gains from artificial intelligence that support valuation multiple expansion, UBS said Monday, raising its price target on the stock to $635 from $598 and maintaining a buy rating.The firm said HCA's scale and data advantages position it to benefit from AI adoption across administrative, operational and clinical workflows, potentially improving efficiency in a hospital sector that has historically seen modest productivity growth.UBS also noted growing investor interest in healthcare companies viewed as potential AI beneficiaries, which could help the stock break above its long-standing 8x to 10x EV/EBITDA trading range.Additionally, the bank said potential Medicaid supplemental payment updates across several states could provide upside to 2026 estimates.Price: 543.99, Change: +11.69, Percent Change: +2.20","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2613733713","isCrawlerRequest":true}